open access

Vol 7, No 2 (2005)
Published online: 2005-09-06
Get Citation

Endovascular treatment of superficial femoral artery occlusion. New possibilities and old limitations

Wacław Kuczmik, Krzysztof Ziaja
Chirurgia Polska 2005;7(2):120-131.

open access

Vol 7, No 2 (2005)
Published online: 2005-09-06

Abstract

The efficacy of angioplasty (PTA) and stent implantation in the treatment of superficial femoral artery (SFA) occlusion is significantly limited by the phenomenon of restenosis. To decrease the risk of restenosis, antiplatelet drugs are widely used and attempts have been made to use new endovascular technology, such as: endovascular brachytherapy, cryotherapy, biodegradating stents, antimitotic substance eluting stents and peripheral stent-grafts. The high divergence in the results of SFA occlusion endovascular treatment causes difficulties in the improvement of new standards of management with SFA occlusion. There is still an insufficient number of large randomized trials on large groups of patients.
Angioplasty still remains the standard treatment of short stenoses. In cases of PTA failure and in long stenoses or occlusions (type B and C according to TASC), the implantation of nitinol stents or peripheral stent-grafts is neccessary to complete the angioplasty. Technological advances enable one to use new techniques (laser, aterectomy), which facilitate long arterial segment recanalization. However, a femoro-popliteal bypass using the patient’s own vein still remains the therapy of choice in cases of long SFA occlusions (type D according to TASC) or the failure of endovascular procedures.

Abstract

The efficacy of angioplasty (PTA) and stent implantation in the treatment of superficial femoral artery (SFA) occlusion is significantly limited by the phenomenon of restenosis. To decrease the risk of restenosis, antiplatelet drugs are widely used and attempts have been made to use new endovascular technology, such as: endovascular brachytherapy, cryotherapy, biodegradating stents, antimitotic substance eluting stents and peripheral stent-grafts. The high divergence in the results of SFA occlusion endovascular treatment causes difficulties in the improvement of new standards of management with SFA occlusion. There is still an insufficient number of large randomized trials on large groups of patients.
Angioplasty still remains the standard treatment of short stenoses. In cases of PTA failure and in long stenoses or occlusions (type B and C according to TASC), the implantation of nitinol stents or peripheral stent-grafts is neccessary to complete the angioplasty. Technological advances enable one to use new techniques (laser, aterectomy), which facilitate long arterial segment recanalization. However, a femoro-popliteal bypass using the patient’s own vein still remains the therapy of choice in cases of long SFA occlusions (type D according to TASC) or the failure of endovascular procedures.
Get Citation

Keywords

superficial femoral artery; angioplasty; stent; restenosis

About this article
Title

Endovascular treatment of superficial femoral artery occlusion. New possibilities and old limitations

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 7, No 2 (2005)

Pages

120-131

Published online

2005-09-06

Bibliographic record

Chirurgia Polska 2005;7(2):120-131.

Keywords

superficial femoral artery
angioplasty
stent
restenosis

Authors

Wacław Kuczmik
Krzysztof Ziaja

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl